Human Immunodeficiency Virus (HIV) gag antigen-specific T-helper and granule-dependent CD8 T-cell activities in exposed but uninfected heterosexual partners of HIV type 1-infected individuals in North India

Clinical and Vaccine Immunology

Volumn 14, Issue 9, 2007, Pages 1196-1202

  Pallikkuth, Suresh ^a   Wanchu, Ajay ^a   Bhatnagar, Archana ^b   Sachdeva, Ravinder Kaur ^a   Sharma, Meera ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD8 ANTIGEN; GAG PROTEIN; GRANZYME B; INTERLEUKIN 2; PERFORIN; VIRUS ANTIGEN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INDIA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEXUAL INTERCOURSE; T LYMPHOCYTE ACTIVATION;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; EPITOPES, T-LYMPHOCYTE; FEMALE; GRANZYMES; HETEROSEXUALITY; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; INDIA; INTERLEUKIN-2; MALE; MIDDLE AGED; PERFORIN; SEXUAL PARTNERS; T-LYMPHOCYTES, HELPER-INDUCER; UNSAFE SEX;

EID: 34948846696     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.0488-06     Document Type: Article

References (38)

1. Andersson, J., H. Behbahani, J. Lieberman, E. Connick, A. Landay, B. Patterson, A. Sonnerborg, K. Lore, S. Uccini, and T. E. Fehniger. 1999. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS 13:1295-1303.
2. Berke, G. 1994. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12:735-773.
3. Bernard, N. F., C. M. Yannakis, J. S. Lee, and C. M. Tsoukas. 1999. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. J. Infect. Dis. 179:538-547.
4. Buseyne, F., S. Le Gall, C. Boccaccio, J. P. Abastado, J. D. Lifson, L. O. Arthur, Y. Riviere, J. M. Heard, and O. Schwartz. 2001. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 7:344-349.
5. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H. N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012-1019.
6. Clerici, M., J. M. Levin, H. A. Kessler, A. Harris, J. A. Berzofsky, A. L. Landay, and G. M. Shearer. 1994. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 271:42-46.
7. Clerici, M., A. V. Sison, J. A. Berzofsky, T. A. Rakusan, C. D. Brandt, M. Ellaurie, M. Villa, C. Colie, D. J. Venzon, and J. L. Sever. 1993. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 7:1427-1433.
8. + cell numbers and clinical staging. J. Clin. Investig. 84:1892-1899.
9. Devito, C., J. Hinkula, R. Kaul, J. Kimani, P. Kiama, L. Lopalco, C. Barass, S. Piconi, D. Trabattoni, J. J. Bwayo, F. Plummer, M. Clerici, and K. Broliden. 2002. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J. Acquir. Immune Defic. Syndr. 30:413-420.
10. Eyeson, J., D. King, M. J. Boaz, E. Sefia, S. Tomkins, A. Waters, P. J. Easterbrook, and A. Vyakarnam. 2003. Evidence for gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects. AIDS 17:2299-2311.
11. + T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J. Exp. Med. 186:455-460.
12. Giorgi, J. V., J. L. Fahey, D. C. Smith, L. E. Hultin, H. L. Cheng, R. T. Mitsuyasu, and R. Detels. 1987. Early effects of HIV on CD4 lymphocytes in vivo. J. Immunol. 138:3725-3730.
13. Goh, W. C., J. Markee, R. E. Akridge, M. Meldorf, L. Musey, T. Karchmer, M. Krone, A. Collier, L. Corey, M. Emerman, and M. J. McElrath. 1999. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T-cell immunity in the absence of inherited CCR5 coreceptor defects. J. Infect. Dis. 179:548-557.
14. + T cells. J. Exp. Med. 186:1407-1418.
15. Henkart, P. A. 1994. Mechanisms of lymphocyte-mediated lymphotoxicity. Annu. Rev. Immunol. 13:31-58.
16. Jennes, W., B. Vuylsteke, M. Y. Borget, V. Traore-Ettiegne, C. Maurice, M. Nolan, J. N. Nkengasong, and L. Kestens. 2004. HIV-specific T helper responses and frequency of exposure among HIV-exposed seronegative female sex workers in Abidjan, Cote d'Ivoire. J. Infect. Dis. 189:602-610.
17. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207-232.
18. + lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J. Clin. Investig. 107:1303-1310.
19. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J. Immunol. 164:1602-1611.
20. + responses. J. Clin. Investig. 107:341-349.
21. Kay, H. D. 1980. A new procedure to overlay diluted blood on Ficoll-Hypaque gradients. J. Immunol. Methods 39:81-83.
22. Larsson, M., J. F. Fonteneau, M. Lirvall, P. Haslett, J. D. Lifson, and N. Bhardwaj. 2002. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. AIDS 16:1319-1329.
23. Lopalco, L., C. Barassi, C. Pastori, R. Longhi, S. E. Burastero, G. Tambussi, F. Mazzotta, A. Lazzarin, M. Clerici, and A. G. Siccardi. 2000. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals downmodulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro. J. Immunol. 164:3426-3433.
24. + T cell cross-priming with exogenous antigens. J. Immunol. 166:7268-7275.
25. + lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. Virology 244:66-73.
26. Portales, P., J. Reynes, R. Rouzier-Panis, V. Bailla, J. Clot, and P. Corbeau. 2003. Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection. AIDS 17:505-511.
27. Reimann, J., and R. Schirmbeck. 1999. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation. Immunol. Rev. 172:131-152.
28. Rowland-Jones, S., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7:448-455.
29. Rowland-Jones, S., T. Dong, K. R Fowke, J. Kimani, P. Krause, H. Newell, T. Blanchard, K. Ariyoshi, J. Oyugi, E. Ngugi, J. Bwayo, K. S. MacDonald, A. J. McMichael, and F. A. Plummer. 1998. Cytotoxic T-cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Investig. 102:1758-1765.
30. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, and T. Corrah. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
31. Schenal, M., S. Lo Caputo, F. Fasano, F. Vichi, M. Saresella, P. Pierotti, M. L. Villa, F. Mazzotta, D. Trabattoni, and M. Clerici. 2005. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients. AIDS 19:653-661.
32. Shankar, P., Z. Xu, and J. Lieberman. 1999. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood 94:3084-3093.
33. Skurnick, J., P. Palumbo, A. DeVico, B. L. Shacklett, F. T. Valentine, M. Merges, R. Kamin-Lewis, J. Mestecky, T. Denny, G. K. Lewis, J. Lloyd, R. Praschunus, A. Baker, D. F. Nixon, S. Stranford, R. Gallo, S. H. Vermund, and D. B. Louria. 2002. Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. J. Infect. Dis. 185:428-438.
34. + cell non-cytotoxic anti-HIV response. Proc. Natl. Acad. Sci. USA 96:1030-1035.
35. Suresh, P., A. Bhatnagar, R. K. Sachdeva, M. Sharma, and A. Wanchu. Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV-1 infected individuals in north India. AIDS. Res. Hum. Retrovir. 23:261-268.
36. Suresh, P., A. Wanchu, R. K. Sachdeva, and A. Bhatnagar. 2006. Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in north India. J. Clin. Immunol. 26:476-484.
37. Trabattoni, D., S. Piconi, M. Biasin, G. Rizzardini, M. Migliorino, E. Seminari, A. Boasso, L. Piacentini, M. L. Villa, R. Maserati, and M. Clerici. 2004. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals. AIDS 18:859-869.
38. Zagury, D., A. Lachgar, V. Chams, L. S Fall, J. Bernard, J. F. Zagury, B. Bizzini, A. Gringeri, E. Santagostino, J. Rappaport, M. Feldman, S. J. O'Brien, A. Burny, and R. C. Gallo. 1998. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc. Natl. Acad. Sci. USA 95:3857-3861.